Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-17

FDA Approved: NICARDIPINE HYDROCHLORIDE — Supplemental Application (Epic Pharma, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Nicardipine hydrochloride from Epic Pharma, LLC, under the ANDA process. This represents a supplemental approval…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicardipine hydrochloride (Nicardipine)

Snippet

SUPPL AP for NICARDIPINE HYDROCHLORIDE (NICARDIPINE HYDROCHLORIDE)